Frontlight ResearchEarly access
Taking people in ItalyPhase 4
Comparing two sedation drugs during endoscopic ultrasound for stomach or pancreatic cancer
Tests remimazolam against propofol to keep adults calm during endoscopic ultrasound.
Key facts
- Who runs it
- Ospedale San Raffaele S.r.l.
- Where
- Milan, ItalySee the site
- Trial code
- Registry title
- Remimazolam versus propofol for deep sedation during Endoscopic Ultrasound (EUS) procedures. A randomized controlled trial.
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 332 people, planned
- Started
- 23 Jun 2026
- Planned end
- 31 Jul 2026
- Type of study
- Interventional
- Record updated
- 10 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who are booked for a planned endoscopic ultrasound of the digestive tract as outpatients. It compares two ways of giving deep sedation.
- Age
- Over 18 years
- Sex
- All sexes can join
Main reasons for not taking part
- Urgent endoscopic ultrasound procedures
- Known reasons why propofol or remimazolam cannot be used
- Procedures that need a breathing tube through the mouth
- Pregnant or breastfeeding women
- Inpatient procedures
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Patients >18 years
- Patients scheduled for elective EUS gastrointestinal procedures
- Signed informed consent
- Outpatient procedures
Who cannot take part
- Patients < 18 years
- Patients scheduled for urgent EUS gastrointestinal procedures
- Known contraindications to the use of propofol and/or remimazolam
- Patient’s refusal to participate
- Procedures that require orotracheal intubation
- Pregnant and breastfeeding women
- Inpatient procedures
This trial is currently available in Italy.
- Ospedale San Raffaele S.r.l.Milan, ItalyTaking people
About the trial
What the trial wants to find out
To compare a remimazolam-based sedation regimen managed by endoscopists to a propofol-based sedation regimen performed by anesthesiologists during EUS gastrointestinal procedures.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- Remimazolam versus propofol for deep sedation during Endoscopic Ultrasound (EUS) procedures. A randomized controlled trial.
- Plain-language title
- Comparing two sedation drugs during endoscopic ultrasound for stomach or pancreatic cancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 10 September 2026